Medistim

Notice of Annual General Meeting in Medistim ASA

(Oslo, 10th of April 2025) Medistim ASA (OSE: MEDI), a niche market leader

within ultrasound technology with headquarters in Norway, that develops and

commercializes medical equipment for use within cardiac, vascular and transplant

surgery, announces the Annual General Meeting for the company.

The Annual General Meeting will take place on the 8th of May 2025 at 10.00

and is held at Medistim’s offices at Økernveien 94 in Oslo. Attached are the

agenda for the meeting, the voting form and the annual report for 2024. It is

possible to give proxy with and without voting instructions. By using a proxy

with voting instructions, the shareholders will vote on the specific issues

without personal attendance. For further information on the use of proxy, see

general information at the bottom of the notice and enclosed proxy forms.

Attached is also the annual report for 2024 for Medistim ASA in PDF format and

in ESEF format. The report is also available on the company web site:

www.medistim.com.

About Medistim:

Medistim was established in 1984 and has a track record of profitable growth

over the past >15 years. The company is a pioneer within its segment, and

continues to invest in new product development. Medistim has wholly owned

subsidiaries with sales organizations in the USA, Canada, China, Germany, UK,

Spain, Denmark, Sweden and Norway, in addition to the about 60 distributors in

Europe, Asia, Middle East, Africa, Canada and South America. For more

information, visit the Medistim home page: www.Medistim.com

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act (Verdipapirhandelloven).

For more information, contact:

President and CEO, Kari E. Krogstad, Medistim ASA

Tel: + 47 918 38 110

CFO, Thomas Jakobsen, Medistim ASA

Tel: + 47 906 59 940

AI Terminal